Mursla Bio Receives FDA Breakthrough Device Designation for EvoLiver Test
Reflects the potential of EvoLiver test to improve early liver cancer detection among high-risk patients
April 23, 2025
Mursla Bio Receives FDA Breakthrough Device Designation for EvoLiver Test
Reflects the potential of EvoLiver test to improve early liver cancer detection among high-risk patients